Opendata, web and dolomites


Coiled-coil mediated exonuclease tethering technology for the enhancement of CRISPR gene editing

Total Cost €


EC-Contrib. €






Project "CCedit" data sheet

The following table provides information about the project.


Organization address
address: HAJDRIHOVA 19
postcode: 1000

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Slovenia [SI]
 Total cost 0 €
 EC max contribution 150˙000 € (0%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-PoC
 Funding Scheme ERC-POC-LS
 Starting year 2020
 Duration (year-month-day) from 2020-02-01   to  2021-07-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KEMIJSKI INSTITUT SI (LJUBLJANA) coordinator 150˙000.00


 Project objective

The discovery and implementation of CRISPR technology represents a milestone for biotechnology and life sciences in general as the genomes of virtually all organisms can be modified by this technology and have already resulted in billions of euros of added value. With this technique, selected genes can be rather easily inactivated (knock out), which is one of the key applications of CRISPR for cell-based therapy and industrial biotechnology. Any improvement of the efficiency of CRISPR therefore has very high value and potential impact. Recently we designed Cas9 DNA targeting and cleavage complex to be tethered to the ExoIII exonuclease via an engineered coiled-coil (CC) dimer, developed in the ERC AdG project MaCChines. We found that it strongly improved inactivation of target genes, even better than direct genetic fusion of Cas9-ExoIII. Since this invention has a substantial translation potential we recently filed a patent application (priority number EP19192490). The strategic frontier of CCedit is to maximise the value of this enhancement of Cas9/CRISPR technology and establish the innovation potential arising from the ERC project MaCChines in the pre-demonstration phase. Specific objectives are to: • Refine the components of the CCedit technology and its implementation for specific applications; • Establish technological viability and its placement within the framework of Cas9/CRISPR technology; • Demonstrate and select most promising implementations of this technology for applications; • Investigate the IP, FTO and policy regulations landscape and further develop the IP portfolio; • Develop the business plan and commercialisation strategy for the technology; • Disseminate information on this technology and raise the interest of companies and other potential users of this technology and obtain links to early stage funding. • Train members of the project team and local community on entrepreneurial skills in biotech

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CCEDIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CCEDIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

NanoPD_P (2020)

High throughput multiplexed trace-analyte screening for diagnostics applications

Read More  

FuncMAB (2019)

High-throughput single-cell phenotypic analysis of functional antibody repertoires

Read More  


Streamlined carbon dioxide conversion in ionic liquids – a platform strategy for modern carbonylation chemistry

Read More  
lastchecktime (2022-10-01 1:19:44) correctly updated